About
Who We Are
Genentech (GNE), a member of the Roche group and founder of the biotechnology industry, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. To solve the world's most complex health challenges, we ask bigger questions that challenge our industry and the boundaries of science to transform society. Our transformational discoveries include the first targeted antibody for cancer and the first medicine...
Updates & Highlights
University of Nevada, Reno · about 1 month ago
From the lab to the boardroom: Biotech alum leads at Genentech
KRGV · about 1 month ago
Genentech - 08/05/2026
Yahoo Finance · about 1 month ago
Recursion Pharmaceuticals (RXRX) Is Up 11.4% After Mixed Q2 Results And Genentech Milestone Update
Recent Openings
View all 7 jobs arrow_forwardMachine Learning Engineer/Senior Machine Learning Engineer - Infra
location_on New York, NY, US
All Jobs
Machine Learning Engineer/Senior Machine Learning Engineer - Infra
location_on New York, NY, US
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Competitive Salary
Market-rate compensation
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Genentech?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentFrom the lab to the boardroom: Biotech alum leads at Genentech
From the lab to the boardroom: Biotech alum leads at Genentech
University of Nevada, Reno · about 1 month ago
Genentech - 08/05/2026
Genentech - 08/05/2026
KRGV · about 1 month ago
Recursion Pharmaceuticals (RXRX) Is Up 11.4% After Mixed Q2 Results And Genentech Milestone Update
Recursion Pharmaceuticals (RXRX) Is Up 11.4% After Mixed Q2 Results And Genentech Milestone Update
Yahoo Finance · about 1 month ago
Recursion Partners with Genentech to Advance First Validated Neuro Target Discovered Through AI Map
Recursion Partners with Genentech to Advance First Validated Neuro Target Discovered Through AI Map
Genetic Engineering and Biotechnology News · about 1 month ago
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
The Daily Tribune News · about 1 month ago
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
Yahoo Finance · about 1 month ago
Genentech | Morning Blend
Genentech | Morning Blend
Tampa Bay 28 · about 1 month ago
Genentech | Morning Blend
Genentech | Morning Blend
Yahoo · about 1 month ago
Genentech Brings New Perjeta Infringement Suit Over Biosimilar
Genentech Brings New Perjeta Infringement Suit Over Biosimilar
Bloomberg Law News · about 1 month ago
Genentech Number of Employees 2026 | Employee Count & Headcount Data
Genentech Number of Employees 2026 | Employee Count & Headcount Data
Revelio Labs · about 1 month ago
Genentech's parent company slims obesity lineup from $3 billion East Bay buyout
Genentech's parent company slims obesity lineup from $3 billion East Bay buyout
The Business Journals · about 2 months ago
MaxCyte Partners With Genentech To Support Cell Therapy Development And Manufacturing
MaxCyte Partners With Genentech To Support Cell Therapy Development And Manufacturing
Pulse 2.0 · about 2 months ago
MaxCyte Partners With Genentech To Support Cell Therapy Development And Manufacturing
MaxCyte Partners With Genentech To Support Cell Therapy Development And Manufacturing
Pulse 2.0 · about 2 months ago
Genentech Increases Lobbying Amid Drug Pricing Pressure
Genentech Increases Lobbying Amid Drug Pricing Pressure
Legis1 · about 2 months ago
MaxCyte stock surges on Genentech technology license deal
MaxCyte stock surges on Genentech technology license deal
Investing.com · about 2 months ago
MaxCyte Enters Technology License Partnership With Genentech
MaxCyte Enters Technology License Partnership With Genentech
marketscreener.com · about 2 months ago
Genentech licenses MaxCyte cell engineering technology
Genentech licenses MaxCyte cell engineering technology
Investing.com · about 2 months ago
MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development
MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development
The Manila Times · about 2 months ago
MaxCyte licenses cell therapy tech to Genentech for research and manufacturing support
MaxCyte licenses cell therapy tech to Genentech for research and manufacturing support
Pluang · about 2 months ago
FDA grants priority review to Genentech’s Gazyva sBLA in pMN
FDA grants priority review to Genentech’s Gazyva sBLA in pMN
The Pharma Letter · about 2 months ago